Nurulimab
Nurulimab (BCD-145) is an anti-cytotoxic T lymphocyte antigen-4 (anti-CTLA-4) humanized monoclonal antibody. Nurulimab can be can be used in research of melanoma.
Read more
€0.00
(tax incl.)
Reference:
HY-P99760
Brand: